Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anti-inflammatory effects of rosiglitazone in stage 4–5 chronic kidney disease
2006-003001-49Phase 2Active
- Sponsor
- Leiden University Medical Center
- Start
- Jun 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of rosiglitazone in chronic kidney disease (CKD), sponsored by Leiden University Medical Center. Primary endpoints: Intima-media thickness carotid artery, Carotid artery calcifications and 1 more. Started Jun 2006; status: active.
02
Drugs
rosiglitazone
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on 2006-003001-49.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003001-49.